HemOncToday.com via MedWorm.com MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'HemOncToday.com' source. Sat, 20 Mar 2010 13:50:31 +0100 Physician cost-profiling may be misleading http://www.medworm.com/index.php?rid=3383995&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62253 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3383995 Fri, 19 Mar 2010 10:08:00 +0100 3383995 Older patients with colon cancer able to tolerate adjuvant chemotherapy http://www.medworm.com/index.php?rid=3380084&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62249 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3380084 Fri, 19 Mar 2010 09:32:00 +0100 3380084 Presurgical ovarian cancer blood test available, covered by Medicare http://www.medworm.com/index.php?rid=3380085&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62187 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3380085 Thu, 18 Mar 2010 14:57:00 +0100 3380085 ESCAPE: Addition of sorafenib to carboplatin and paclitaxel had no effect on survival in NSCLC http://www.medworm.com/index.php?rid=3380086&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62203 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3380086 Thu, 18 Mar 2010 13:20:00 +0100 3380086 Stereotactic body radiation controlled inoperable lung cancer tumors http://www.medworm.com/index.php?rid=3380087&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62188 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3380087 Thu, 18 Mar 2010 11:34:00 +0100 3380087 Access to palliative care varies widely http://www.medworm.com/index.php?rid=3375498&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62175 Cancer patients rarely receive palliative care until just before the last days of life, surveys indicate. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3375498 Wed, 17 Mar 2010 15:17:00 +0100 3375498 PLATO: Better survival with ticagrelor vs. clopidogrel http://www.medworm.com/index.php?rid=3375499&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62168 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3375499 Wed, 17 Mar 2010 15:08:00 +0100 3375499 Low-income women offered appropriate follow-up after abnormal mammogram http://www.medworm.com/index.php?rid=3375500&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62120 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3375500 Wed, 17 Mar 2010 11:52:00 +0100 3375500 Treating melanoma in the elderly a significant economic burden http://www.medworm.com/index.php?rid=3375501&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62096 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3375501 Wed, 17 Mar 2010 10:36:00 +0100 3375501 FDA adds boxed warning to clopidogrel http://www.medworm.com/index.php?rid=3371361&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62078 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371361 Wed, 17 Mar 2010 08:48:00 +0100 3371361 Laparoscopic surgery may be viable option for treatment of certain gynecologic cancers http://www.medworm.com/index.php?rid=3371362&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62049 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371362 Tue, 16 Mar 2010 15:17:00 +0100 3371362 HPV vaccine reduced further disease in women treated for cancer precursors http://www.medworm.com/index.php?rid=3371363&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62043 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371363 Tue, 16 Mar 2010 15:13:00 +0100 3371363 Patients with melanoma have prolonged increased risk of subsequent melanoma http://www.medworm.com/index.php?rid=3371364&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62035 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371364 Tue, 16 Mar 2010 12:47:00 +0100 3371364 Betrixaban had dose-dependent effect on major, non-major bleeding http://www.medworm.com/index.php?rid=3371365&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62006 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371365 Tue, 16 Mar 2010 11:14:00 +0100 3371365 Media coverage about cancer mortality, end-of-life issues lacking http://www.medworm.com/index.php?rid=3371366&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D62003 Balanced coverage would give the public more accurate knowledge of cancer, researchers said. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3371366 Tue, 16 Mar 2010 10:22:00 +0100 3371366 Incidence of nonmelanoma skin cancers increasing http://www.medworm.com/index.php?rid=3367047&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61983 The disease may affect more people than all other cancers combined. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3367047 Mon, 15 Mar 2010 16:19:00 +0100 3367047 Dexamethasone plus rituximab improved platelet counts in patients with ITP http://www.medworm.com/index.php?rid=3367048&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61957 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3367048 Mon, 15 Mar 2010 12:28:00 +0100 3367048 Denileukin diftitox improved overall response rate in cutaneous T-cell lymphoma http://www.medworm.com/index.php?rid=3360398&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61889 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3360398 Fri, 12 Mar 2010 10:11:00 +0100 3360398 FDA will continue review of bisphosphonate, femur fracture risk http://www.medworm.com/index.php?rid=3360399&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61887 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3360399 Fri, 12 Mar 2010 10:10:00 +0100 3360399 CD68+ cells associated with primary treatment failure, poor survival in Hodgkin’s lymphoma http://www.medworm.com/index.php?rid=3355717&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61844 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3355717 Thu, 11 Mar 2010 13:26:00 +0100 3355717 Boxed warning added to WinRho http://www.medworm.com/index.php?rid=3355718&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61805 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3355718 Thu, 11 Mar 2010 10:58:00 +0100 3355718 Gene expression levels influenced prostate cancer outcomes http://www.medworm.com/index.php?rid=3355719&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61793 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3355719 Thu, 11 Mar 2010 09:29:00 +0100 3355719 Bill would further delay Medicare physician payment cut http://www.medworm.com/index.php?rid=3355720&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61874 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3355720 Thu, 11 Mar 2010 08:42:00 +0100 3355720 Recommendations issued to reduce incidence of VTE http://www.medworm.com/index.php?rid=3351537&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61773 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3351537 Wed, 10 Mar 2010 14:40:00 +0100 3351537 New oral anticoagulants may replace warfarin http://www.medworm.com/index.php?rid=3355721&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61744 With some agents already approved in Europe and Canada, the long-awaited move away from warfarin may be starting. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3355721 Wed, 10 Mar 2010 12:10:00 +0100 3355721 Warfarin use increased risk for brain bleed after IV tissue plasminogen activator use http://www.medworm.com/index.php?rid=3351538&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61762 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3351538 Wed, 10 Mar 2010 10:39:00 +0100 3351538 Blacks present with different histologic subtypes of renal cell carcinoma http://www.medworm.com/index.php?rid=3351539&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61761 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3351539 Wed, 10 Mar 2010 10:31:00 +0100 3351539 Age, sex, socioecomonic factors affected access to and provision of care in Britain’s NHS Cancer Plan http://www.medworm.com/index.php?rid=3347767&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61755 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3347767 Wed, 10 Mar 2010 08:58:00 +0100 3347767 PSA screening in the United States detected fewer prostate cancers than in ERSPC–Rotterdam http://www.medworm.com/index.php?rid=3347768&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61754 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3347768 Wed, 10 Mar 2010 08:55:00 +0100 3347768 TN category influenced survival, relapse, colostomy failure in anal cancer http://www.medworm.com/index.php?rid=3347769&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61753 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3347769 Wed, 10 Mar 2010 08:51:00 +0100 3347769 Sorafenib extended OS, TTP in HCC irrespective of ALT/AST/AFP levels http://www.medworm.com/index.php?rid=3347770&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61751 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3347770 Wed, 10 Mar 2010 08:49:00 +0100 3347770 Controlling dietary polyamines may prevent colorectal adenomas http://www.medworm.com/index.php?rid=3347771&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61752 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3347771 Wed, 10 Mar 2010 08:48:00 +0100 3347771 Use of palliative sedation in Belgium has almost doubled in recent years http://www.medworm.com/index.php?rid=3343558&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61673 Established guidelines would likely help improve care at the end of life. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3343558 Mon, 08 Mar 2010 16:13:00 +0100 3343558 Bisphosphonate use associated with decreased risk for breast cancer http://www.medworm.com/index.php?rid=3343559&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61666 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3343559 Mon, 08 Mar 2010 13:32:00 +0100 3343559 Only 26.5% of penile cancers treated according to guidelines http://www.medworm.com/index.php?rid=3343560&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61654 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3343560 Sun, 07 Mar 2010 10:36:00 +0100 3343560 Association between weight, colorectal cancer risk varied by microsatellite stability status http://www.medworm.com/index.php?rid=3343561&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61652 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3343561 Sun, 07 Mar 2010 10:25:00 +0100 3343561 Updated IMPACT: survival benefit for sipuleucel-T upheld in metastatic castration-resistant prostate cancer http://www.medworm.com/index.php?rid=3336469&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61644 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3336469 Sat, 06 Mar 2010 07:56:00 +0100 3336469 Interstitial radiation associated with better health-related QOL in low-risk prostate cancer http://www.medworm.com/index.php?rid=3336470&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61643 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3336470 Sat, 06 Mar 2010 07:34:00 +0100 3336470 Cystoscopy alone most cost-effective method to detect bladder cancer recurrence http://www.medworm.com/index.php?rid=3336471&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61628 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3336471 Fri, 05 Mar 2010 09:59:00 +0100 3336471 Hormone therapy plus radiation improved OS in intermediate-risk, early-stage prostate cancers http://www.medworm.com/index.php?rid=3336472&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61627 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3336472 Fri, 05 Mar 2010 09:55:00 +0100 3336472 Aggressive chemoradiotherapy showed similar results in older patients http://www.medworm.com/index.php?rid=3332524&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61619 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3332524 Thu, 04 Mar 2010 15:28:00 +0100 3332524 Transoral robotic surgery showed good oncologic, functional outcomes http://www.medworm.com/index.php?rid=3332525&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61613 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3332525 Thu, 04 Mar 2010 15:20:00 +0100 3332525 Prolonged treatment delay did not affect outcomes in SCCHN http://www.medworm.com/index.php?rid=3332526&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61584 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3332526 Thu, 04 Mar 2010 15:03:00 +0100 3332526 Urine test predicted results of prostate biopsy http://www.medworm.com/index.php?rid=3332527&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61595 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3332527 Thu, 04 Mar 2010 11:33:00 +0100 3332527 TROPIC: Cabazitaxel improved survival by 30% in metastatic castration–resistant prostate cancer http://www.medworm.com/index.php?rid=3332528&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61586 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3332528 Thu, 04 Mar 2010 10:05:00 +0100 3332528 More aggressive ESA, iron use associated with decreased mortality in anemia patients on hemodialysis http://www.medworm.com/index.php?rid=3328355&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61581 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3328355 Wed, 03 Mar 2010 16:45:00 +0100 3328355 American Cancer Society revises prostate cancer screening guidelines http://www.medworm.com/index.php?rid=3328356&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61540 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3328356 Wed, 03 Mar 2010 14:02:00 +0100 3328356 Senate bill delays 21% Medicare physician payment cut http://www.medworm.com/index.php?rid=3328357&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61535 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3328357 Wed, 03 Mar 2010 12:12:00 +0100 3328357 State payer mandates for cancer clinical trials varied widely http://www.medworm.com/index.php?rid=3328358&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61529 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3328358 Wed, 03 Mar 2010 11:43:00 +0100 3328358 Proton beam radiation had good long-term outcomes in sinonasal malignancies http://www.medworm.com/index.php?rid=3328359&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61492 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3328359 Wed, 03 Mar 2010 10:05:00 +0100 3328359 Higher IGF-I associated with increased cancer mortality risk in older men http://www.medworm.com/index.php?rid=3323810&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61447 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3323810 Tue, 02 Mar 2010 15:17:00 +0100 3323810 PEARL: High-dose lasofoxifene reduced risk for fracture, breast cancer, coronary events http://www.medworm.com/index.php?rid=3323811&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61446 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3323811 Tue, 02 Mar 2010 15:13:00 +0100 3323811 One in eight parents considered hastening death of child dying of cancer http://www.medworm.com/index.php?rid=3323812&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61432 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3323812 Tue, 02 Mar 2010 09:11:00 +0100 3323812 End-of-life experiences for children with brain tumors also challenging for parents http://www.medworm.com/index.php?rid=3319259&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61431 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3319259 Tue, 02 Mar 2010 08:54:00 +0100 3319259 Clinical trial participation did not result in better survival in pediatric ALL http://www.medworm.com/index.php?rid=3319260&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61430 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3319260 Mon, 01 Mar 2010 17:24:00 +0100 3319260 Young adults more likely to die from NHL than children, adolescents http://www.medworm.com/index.php?rid=3319261&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61429 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3319261 Mon, 01 Mar 2010 17:18:00 +0100 3319261 Axillary lymph node micrometastases associated with poor breast cancer prognosis http://www.medworm.com/index.php?rid=3319262&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61383 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3319262 Mon, 01 Mar 2010 11:17:00 +0100 3319262 Maximal SUV predicted survival outcomes in SCCHN http://www.medworm.com/index.php?rid=3319263&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61381 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3319263 Mon, 01 Mar 2010 11:12:00 +0100 3319263 Unilateral radiotherapy effective treatment for squamous cell carcinoma of the tonsil http://www.medworm.com/index.php?rid=3312771&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61354 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3312771 Fri, 26 Feb 2010 12:15:00 +0100 3312771 Larynx dysfunction reduced using chemotherapy, radiation for larynx preservation http://www.medworm.com/index.php?rid=3312772&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61353 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3312772 Fri, 26 Feb 2010 12:13:00 +0100 3312772 Contralateral prophylactic mastectomy increased survival in some younger patients with early-stage breast cancer http://www.medworm.com/index.php?rid=3312773&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61328 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3312773 Fri, 26 Feb 2010 09:41:00 +0100 3312773 Pelvic plus para-aortic lymphadenectomy best approach for intermediate, high-risk endometrial cancer http://www.medworm.com/index.php?rid=3312774&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61327 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3312774 Fri, 26 Feb 2010 09:37:00 +0100 3312774 Combination MRI, mammography screening more effective in women with BRCA1 mutations http://www.medworm.com/index.php?rid=3308168&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61282 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308168 Thu, 25 Feb 2010 10:07:00 +0100 3308168 Preventive tamoxifen use low in 2000, 2005 http://www.medworm.com/index.php?rid=3308169&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61277 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308169 Thu, 25 Feb 2010 09:39:00 +0100 3308169 Age affected coping strategies among patients with sickle cell disease http://www.medworm.com/index.php?rid=3308170&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61276 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308170 Thu, 25 Feb 2010 09:37:00 +0100 3308170 HPV vaccines decreased the risk for variety of HPV–related diseases HPV vaccines decreased the risk for variety of HPV–related diseases http://www.medworm.com/index.php?rid=3308171&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61275 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308171 Thu, 25 Feb 2010 09:36:00 +0100 3308171 Exposure to higher levels of endogenous hormones associated with increased breast cancer risk http://www.medworm.com/index.php?rid=3308172&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61274 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308172 Thu, 25 Feb 2010 09:33:00 +0100 3308172 Office of Oncology Drug Products approved 53 of 60 applications in 2.5 years http://www.medworm.com/index.php?rid=3308173&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61273 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308173 Thu, 25 Feb 2010 09:31:00 +0100 3308173 Administrative issues plague patient access schemes in Britain http://www.medworm.com/index.php?rid=3308174&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61272 Results show providers lack ability, personnel to efficiently manage plans. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3308174 Thu, 25 Feb 2010 09:29:00 +0100 3308174 Is trastuzumab plus endocrine therapy sufficient for patients who are triple positive but node negative, or do they also require chemotherapy? http://www.medworm.com/index.php?rid=3303724&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61262 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3303724 Thu, 25 Feb 2010 08:50:00 +0100 3303724 Best treatment for small HER-2–positive, node-negative breast cancers unknown http://www.medworm.com/index.php?rid=3303725&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61261 Although there is little direct evidence showing efficacy, trastuzumab may be the best available option. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3303725 Thu, 25 Feb 2010 08:34:00 +0100 3303725 Cancer survivorship affected quality of life in young male survivors http://www.medworm.com/index.php?rid=3303726&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61243 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3303726 Wed, 24 Feb 2010 09:48:00 +0100 3303726 Open, laparoscopic prostate surgery showed similar rates of postoperative mortality, morbidity http://www.medworm.com/index.php?rid=3303727&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61242 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3303727 Wed, 24 Feb 2010 09:33:00 +0100 3303727 Racial disparities exist in lung cancer knowledge http://www.medworm.com/index.php?rid=3299570&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61192 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3299570 Tue, 23 Feb 2010 09:40:00 +0100 3299570 European patients with cancer may not receive appropriate pain relief due to opioid drug restrictions http://www.medworm.com/index.php?rid=3299571&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61191 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3299571 Tue, 23 Feb 2010 09:35:00 +0100 3299571 President proposes $100 billion reduction of U.S. deficit in next 10 years http://www.medworm.com/index.php?rid=3295642&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61182 Proposal offers Americans more control over health care choices. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3295642 Mon, 22 Feb 2010 17:01:00 +0100 3295642 Study identifies racial and ethnic disparities in surgical care http://www.medworm.com/index.php?rid=3295643&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61151 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3295643 Mon, 22 Feb 2010 10:38:00 +0100 3295643 Rituximab combination approved to treat adult CLL http://www.medworm.com/index.php?rid=3289111&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61136 The drug is used in combination with fludarabine and cyclophosphamide. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3289111 Fri, 19 Feb 2010 14:55:00 +0100 3289111 Increased duration of estrogen plus progestin use increased risk for lung cancer http://www.medworm.com/index.php?rid=3285163&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61125 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3285163 Fri, 19 Feb 2010 08:46:00 +0100 3285163 Boxed warning added to deferasirox label http://www.medworm.com/index.php?rid=3285164&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61123 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3285164 Thu, 18 Feb 2010 14:52:00 +0100 3285164 Multitargeted ‘chemo-switch’ regimen improved PFS in renal cell carcinoma over historical numbers http://www.medworm.com/index.php?rid=3285165&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61107 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3285165 Thu, 18 Feb 2010 10:47:00 +0100 3285165 Platelet transfusion dose did not affect bleeding in hypoproliferative thrombocytopenia http://www.medworm.com/index.php?rid=3285166&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61108 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3285166 Thu, 18 Feb 2010 10:42:00 +0100 3285166 FDA approves new safety plan for ESAs in cancer http://www.medworm.com/index.php?rid=3280997&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61081 Only hospitals and health care professionals who have completed a training program are allowed to prescribe and dispense ESAs. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3280997 Wed, 17 Feb 2010 14:33:00 +0100 3280997 Low benefit for HPV vaccination, screening in older women http://www.medworm.com/index.php?rid=3280998&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61075 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3280998 Wed, 17 Feb 2010 11:32:00 +0100 3280998 Erlotinib only ‘marginally cost-effective’ for NSCLC http://www.medworm.com/index.php?rid=3280999&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61069 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3280999 Wed, 17 Feb 2010 10:41:00 +0100 3280999 Denosumab showed promise in patients with giant cell tumor of bone http://www.medworm.com/index.php?rid=3277136&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61022 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3277136 Tue, 16 Feb 2010 12:00:00 +0100 3277136 POST: Patients with superficial venous thrombosis had or developed VTE http://www.medworm.com/index.php?rid=3277137&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61029 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3277137 Tue, 16 Feb 2010 10:56:00 +0100 3277137 Interferon-alfa sustained remission following imatinib discontinuation in CML http://www.medworm.com/index.php?rid=3277138&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D61023 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3277138 Tue, 16 Feb 2010 10:23:00 +0100 3277138 NSAIDs not associated with cutaneous squamous cell carcinoma risk http://www.medworm.com/index.php?rid=3273584&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60983 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3273584 Mon, 15 Feb 2010 16:02:00 +0100 3273584 Cladribine led to long-term eradication of hairy cell leukemia http://www.medworm.com/index.php?rid=3273585&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60977 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3273585 Mon, 15 Feb 2010 15:20:00 +0100 3273585 Combination therapy did not improve survival for patients with renal cell carcinoma http://www.medworm.com/index.php?rid=3273586&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60927 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3273586 Mon, 15 Feb 2010 14:36:00 +0100 3273586 Radiotherapy increased cardiovascular, overall mortality in childhood cancer survivors http://www.medworm.com/index.php?rid=3267884&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60878 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3267884 Fri, 12 Feb 2010 10:18:00 +0100 3267884 Second malignant neoplasm risk high for Hodgkin’s lymphoma, despite initial low-dose radiation http://www.medworm.com/index.php?rid=3263955&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60852 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3263955 Thu, 11 Feb 2010 13:05:00 +0100 3263955 Postsurgical concurrent letrozole plus radiotherapy safe for early stage breast cancer http://www.medworm.com/index.php?rid=3260294&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60805 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3260294 Thu, 11 Feb 2010 08:15:00 +0100 3260294 Hypofractionated radiation equivalent to standard radiation for breast cancer at 10-years http://www.medworm.com/index.php?rid=3260295&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60800 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3260295 Wed, 10 Feb 2010 18:23:00 +0100 3260295 Diagnosing PNH: how and whom http://www.medworm.com/index.php?rid=3267885&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60870 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3267885 Wed, 10 Feb 2010 11:03:00 +0100 3267885 SSRI paroxetine use during tamoxifen treatment increased risk for breast cancer mortality http://www.medworm.com/index.php?rid=3260296&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60768 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3260296 Wed, 10 Feb 2010 09:32:00 +0100 3260296 Access to care, pain relief still problems for sickle cell patients http://www.medworm.com/index.php?rid=3263956&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60868 Even though expert panels recommend hydroxyurea therapy and clinical trial data assure its safety and efficacy, confounding barriers continue to restrict its use. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3263956 Wed, 10 Feb 2010 08:50:00 +0100 3263956 FDA aims to reduce unnecessary radiation exposure with new initiative http://www.medworm.com/index.php?rid=3256023&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60753 The agency will target medical imaging procedures including CT, nuclear medicine studies and fluoroscopy. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3256023 Wed, 10 Feb 2010 08:04:00 +0100 3256023 Identified gene variations associated with recurrence-free survival in NSCLC http://www.medworm.com/index.php?rid=3256024&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60747 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3256024 Tue, 09 Feb 2010 16:05:00 +0100 3256024 Active inflammatory bowel disease greatly increased risk for VTE http://www.medworm.com/index.php?rid=3256025&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60722 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3256025 Tue, 09 Feb 2010 09:59:00 +0100 3256025 Automated telephone outreach with speech recognition did not improve rates of colorectal cancer screening http://www.medworm.com/index.php?rid=3256026&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60719 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3256026 Tue, 09 Feb 2010 09:53:00 +0100 3256026 Hypofractionated radiation led to better quality of life in breast cancer http://www.medworm.com/index.php?rid=3251935&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60694 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3251935 Mon, 08 Feb 2010 13:59:00 +0100 3251935 Financial status associated with anxiety and depression in women with DCIS http://www.medworm.com/index.php?rid=3251936&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60686 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3251936 Mon, 08 Feb 2010 12:02:00 +0100 3251936 HPV vaccines decreased the risk for variety of HPV–related diseases http://www.medworm.com/index.php?rid=3251937&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60687 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3251937 Mon, 08 Feb 2010 11:42:00 +0100 3251937 Initiatives aim to improve screening rates for colorectal cancer http://www.medworm.com/index.php?rid=3245160&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60660 NIH panel concludes insurance, access most important factors in decision to get screened. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3245160 Fri, 05 Feb 2010 12:16:00 +0100 3245160 HPV-associated base of tongue squamous cell carcinoma incidence increasing in Sweden http://www.medworm.com/index.php?rid=3245161&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60649 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3245161 Fri, 05 Feb 2010 10:23:00 +0100 3245161 Life expectancy long, but not normal in patients who survived five years after hematopoietic cell transplantation http://www.medworm.com/index.php?rid=3245162&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60648 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3245162 Fri, 05 Feb 2010 10:07:00 +0100 3245162 Recession expected to affect growth in national health expenditures http://www.medworm.com/index.php?rid=3240927&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60644 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3240927 Thu, 04 Feb 2010 16:47:00 +0100 3240927 Patients with certain HL at risk for transformation to aggressive lymphoma years later http://www.medworm.com/index.php?rid=3240928&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60639 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3240928 Thu, 04 Feb 2010 15:16:00 +0100 3240928 Enzastaurin not superior to lomustine for recurrent glioblastoma http://www.medworm.com/index.php?rid=3240929&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60638 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3240929 Thu, 04 Feb 2010 14:44:00 +0100 3240929 Sunitinib improved survival, response in pancreatic neuroendocrine tumors http://www.medworm.com/index.php?rid=3237014&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60621 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237014 Thu, 04 Feb 2010 08:19:00 +0100 3237014 Peritoneal cytology conversion post-chemotherapy improved disease-specific survival in gastric cancer http://www.medworm.com/index.php?rid=3237015&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60620 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237015 Thu, 04 Feb 2010 08:15:00 +0100 3237015 Sentinel node concept validated in early gastric cancer http://www.medworm.com/index.php?rid=3237016&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60617 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237016 Wed, 03 Feb 2010 15:06:00 +0100 3237016 Metformin use lowered risk for cancer mortality http://www.medworm.com/index.php?rid=3237017&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60615 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237017 Wed, 03 Feb 2010 14:52:00 +0100 3237017 Meta-analysis: Withholding anticoagulants after negative ultrasound led to low risk for VTE http://www.medworm.com/index.php?rid=3237018&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60592 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237018 Wed, 03 Feb 2010 11:28:00 +0100 3237018 Prostate cancer diagnosis increased immediate risk for suicide, cardiovascular death http://www.medworm.com/index.php?rid=3237019&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60584 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3237019 Wed, 03 Feb 2010 10:20:00 +0100 3237019 Ten-year post-transplant survival similar between stem cell, bone marrow transplantation in leukemia patients http://www.medworm.com/index.php?rid=3232802&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60559 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3232802 Tue, 02 Feb 2010 11:00:00 +0100 3232802 Advisory: ADT for prostate cancer may increase cardiovascular risk, mortality http://www.medworm.com/index.php?rid=3232803&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60567 Physicians treating for cancer should weigh risks and benefits of treatment, according to advisory. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3232803 Tue, 02 Feb 2010 10:56:00 +0100 3232803 Gadolinium-enhanced MRI moderately improved accuracy for lymph node detection http://www.medworm.com/index.php?rid=3228602&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60558 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3228602 Tue, 02 Feb 2010 08:09:00 +0100 3228602 FDA approves lapatinib plus letrozole for HER-2–positive, HR-positive, metastatic breast cancer http://www.medworm.com/index.php?rid=3228603&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60521 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3228603 Mon, 01 Feb 2010 10:35:00 +0100 3228603 Stereotactic radiotherapy, wedge resection options for borderline operable NSCLC http://www.medworm.com/index.php?rid=3221660&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60490 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3221660 Fri, 29 Jan 2010 11:05:00 +0100 3221660 Cancer in children did not affect parental divorce rates http://www.medworm.com/index.php?rid=3221661&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60482 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3221661 Fri, 29 Jan 2010 09:39:00 +0100 3221661 Prostate cancer treatment disparities found for low-income patients at public, private facilities http://www.medworm.com/index.php?rid=3221662&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60481 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3221662 Fri, 29 Jan 2010 09:36:00 +0100 3221662 Novel induction chemotherapy regimen, radiation effective for locally advanced pancreatic adenocarcinoma http://www.medworm.com/index.php?rid=3217885&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60468 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3217885 Thu, 28 Jan 2010 14:48:00 +0100 3217885 Many pediatric oncologists unfamiliar with follow-up guidelines for childhood cancer survivors http://www.medworm.com/index.php?rid=3217886&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60450 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3217886 Thu, 28 Jan 2010 09:51:00 +0100 3217886 Meta-analysis: Quitting smoking after diagnosis of early stage lung cancer improved survival http://www.medworm.com/index.php?rid=3217887&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60449 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3217887 Thu, 28 Jan 2010 09:30:00 +0100 3217887 Pazopanib improved PFS in advanced, metastatic renal cell cancer http://www.medworm.com/index.php?rid=3213769&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60447 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3213769 Thu, 28 Jan 2010 08:07:00 +0100 3213769 Updated CRYSTAL: KRAS predictive of outcomes in CRC treated with cetuximab plus FOLFIRI http://www.medworm.com/index.php?rid=3217888&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60471 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3217888 Thu, 28 Jan 2010 07:42:00 +0100 3217888 Childhood leukemia, CNS tumor survivors had lower educational attainment http://www.medworm.com/index.php?rid=3213770&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60439 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3213770 Wed, 27 Jan 2010 16:08:00 +0100 3213770 Pathologic data correlated with relapse-free survival in primary GIST http://www.medworm.com/index.php?rid=3213771&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60430 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3213771 Wed, 27 Jan 2010 13:43:00 +0100 3213771 Bortezomib label revised for patients with hepatic impairment http://www.medworm.com/index.php?rid=3209609&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60389 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3209609 Tue, 26 Jan 2010 14:07:00 +0100 3209609 HIV-related esophageal carcinoma similar to that seen in non-HIV patients http://www.medworm.com/index.php?rid=3209610&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60386 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3209610 Tue, 26 Jan 2010 12:47:00 +0100 3209610 Poxvirus vaccine extended survival in castration-resistant metastatic prostate cancer http://www.medworm.com/index.php?rid=3209611&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60384 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3209611 Tue, 26 Jan 2010 11:45:00 +0100 3209611 Neoadjuvant chemotherapy combo well-tolerated in poor-risk rectal cancer http://www.medworm.com/index.php?rid=3205735&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60369 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205735 Tue, 26 Jan 2010 08:19:00 +0100 3205735 Panitumumab/FOLFIRI improved PFS in wild-type KRAS metastatic colorectal cancer http://www.medworm.com/index.php?rid=3205736&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60356 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205736 Mon, 25 Jan 2010 13:26:00 +0100 3205736 Panitumumab plus FOLFOX4 extended PFS in wild-type KRAS metastatic colorectal cancer http://www.medworm.com/index.php?rid=3205737&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60355 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205737 Mon, 25 Jan 2010 13:13:00 +0100 3205737 The role of the patient advocate http://www.medworm.com/index.php?rid=3205738&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60332 An advocate can look out for your patients when they cannot look out for themselves. (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205738 Mon, 25 Jan 2010 09:58:00 +0100 3205738 A tragic loss http://www.medworm.com/index.php?rid=3205739&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60331 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205739 Mon, 25 Jan 2010 09:53:00 +0100 3205739 Preventing infectious complications in patients with chronic lymphocytic leukemia http://www.medworm.com/index.php?rid=3205740&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60330 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3205740 Mon, 25 Jan 2010 09:50:00 +0100 3205740 Sorafenib did not extend time to progression in advanced HCC after transarterial chemoembolization http://www.medworm.com/index.php?rid=3202505&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60323 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3202505 Sun, 24 Jan 2010 08:44:00 +0100 3202505 TOGA: Addition of trastuzumab to therapy did not affect QoL in gastric cancer http://www.medworm.com/index.php?rid=3199029&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60322 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3199029 Sat, 23 Jan 2010 08:01:00 +0100 3199029 Polymorphism in the CD44 gene predicted aggressive gastric cancer http://www.medworm.com/index.php?rid=3199030&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60290 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3199030 Fri, 22 Jan 2010 09:10:00 +0100 3199030 Ch17CEP duplication predicted anthracycline benefit in early breast cancer http://www.medworm.com/index.php?rid=3195002&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60288 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3195002 Fri, 22 Jan 2010 08:36:00 +0100 3195002 Vandetanib may be effective option for treatment of advanced hereditary medullary thyroid cancer http://www.medworm.com/index.php?rid=3195003&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60287 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3195003 Fri, 22 Jan 2010 08:29:00 +0100 3195003 Blood test for CD24 detected adenomas, colorectal cancer http://www.medworm.com/index.php?rid=3190463&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60243 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3190463 Thu, 21 Jan 2010 08:47:00 +0100 3190463 Novel immunoassay detected early stage pancreatic cancer http://www.medworm.com/index.php?rid=3190464&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60242 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3190464 Thu, 21 Jan 2010 08:41:00 +0100 3190464 XELOX improved DFS in patients of all ages with stage III colon cancer http://www.medworm.com/index.php?rid=3195004&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60265 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3195004 Thu, 21 Jan 2010 07:37:00 +0100 3195004 Cochrane review finds chemoradiotherapy improved survival in women with cervical cancer http://www.medworm.com/index.php?rid=3186700&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60197 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3186700 Wed, 20 Jan 2010 08:14:00 +0100 3186700 PLATO: Ticagrelor associated with reduced outcomes, mortality in patients with ACS http://www.medworm.com/index.php?rid=3182913&cid=s_39076_6_f&fid=39076&url=http%3A%2F%2Fwww.HemOncToday.com%2Farticle.aspx%3Frid%3D60060 (Source: HemOncToday.com) HemOncToday.com info http://www.medworm.com/rss/comments.php?id=3182913 Tue, 19 Jan 2010 13:51:09 +0100 3182913